Vermillion, Johns Hopkins to Continue Collaboration on Cancer Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – Vermillion today said that it has renewed a long-standing collaboration with Johns Hopkins University to develop biomarkers that can be potentially used as molecular diagnostics for cancer.
Under the terms of the agreement, Vermillion will have access to exclusive commercial rights to any discoveries from the partnership. Other terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.